Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production

Pharmaceutical Research

Volumn 14, Issue 1, 1997, Pages 73-79

  Cruz, Teresa ^a   Gaspar, Rogério ^a   Donato, Ana ^a   Lopes, Celeste ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cellular toxicity; Macrophages; Nanoparticles; NBT reduction; NO production

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYANOACRYLATE DERIVATIVE; DRUG CARRIER; NANOPARTICLE; NITRIC OXIDE; POLYMER; REACTIVE OXYGEN METABOLITE; TETRAZOLIUM;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL STRUCTURE; CELL VIABILITY; CYTOTOXICITY; FEMALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYANOACRYLATES; DRUG CARRIERS; FEMALE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRITES; NITROBLUE TETRAZOLIUM; POLYMERS; RESPIRATORY BURST; TETRAZOLIUM SALTS; THIAZOLES; THIOGLYCOLATES;

EID: 0031042535     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012059501947     Document Type: Article

References (20)

1. J. Kreuter. Eur. J. Drug Metab. and Pharmacokinetics 3:253-256 (1994).
2. E. M. Gipps, P. Groscurth, J. Kreuter, and P. P. Speiser. J. Pharm. Sci. 77:208-209 (1988).
3. K. Decker. Eur. J. Biochem. 192:245-261 (1990).
4. U. K. Meßmer, E. G. Lapetina, and B. Brüne. Molecular Pharmacol. 47:757-765 (1995).
5. A. E. Stuart, J. A. Habeshaw, and A. E. Davidson. In D. M. Weir, Cellular Immunology, Blackwell Scientific Publications, Oxford-London-Edinburgh-Melboume, 1973, pp 24.1-24.26.
6. R. Gaspar, V. Préat, F. R. Opperdoes, and M. Roland. Pharm. Res. 9:782-787 (1992).
7. C. Verdun, P. Couvreur, H. Vranckx, V. Lenaerts, and M. Roland. J. Control. Rel. 3:205-210 (1986).
8. M. C. Lopes, L. Guilhermino, A. Donato, L. Silveira, A. M. V. M. Soares, and A. P. Carvalho. Toxic. in vitro 8:831-834 (1994).
9. E. Pick. Methods Enzymol. 132:407-421 (1986).
10. J. E. Ogden and P. K. Moore. Trends in Biotechnol. 13:70-78 (1995).
11. C. Lourenço, M. Teixeira, S. Simōes, and R. Gaspar. Int. J. Pharm. 138:1-12 (1996).
12. E. M. Gipps, P. Groscurdl, J. Kreuter, and P. Speiser. Int. J. Pharm. 40:23-31 (1987).
13. C. Lherm, R. H. Müller, F. Puisieux, and P. Couvreur. Int. J. Pharm. 84:13-22 (1992).
14. H. Pinto-Alphandary, O. Balland, M. Laurent, A. Andremont, F. Puisieux, and P. Couvreur. Pharm. Res. 11:38-46 (1994).
15. C. E. Alford, T. E. King, and P. A. Campbell. J. Exp. Med. 174:459-466 (1991).
16. F. Nemati, C. Dubernet, A. Colin de Verdière, M. F. Pouppon, L. Treupel-Acar, F. Puisieux, and P. Couvreur. Int. J. Pharm. 102:55-62 (1994).
17. L. Vansnick, P. Couvreur, D. Leyh, and M. Roland. Pharm. Res. 1:203-208 (1985).
18. V. Lenaerts, P. Couvreur, D. Christiaens-Leyh, E. Joiris, M. Roland, B. Rollman, and P. Speiser. Biomaterials 5:65-68 (1984).
19. M. Stein and E. Harnacher. Int. J. Pharm. 80:R11-R13 (1992).
20. R. Fernández-Urrusuno, E. Fattal, D. Porquet, J. Féger, and P. Couvreur. Pharm. Res. 12:1385-1387 (1995).